1. The tardive dyskinesia syndrome;D, I.Tarsy; RJ, Baldessarini;Clinical Neuropharmacology
2. Management of tardive dyskinesia: current update;Simpson, G.M.; Pi, E.H.; Sramek, J.J.;Drugs,1976
3. The pathophysiological basis of tardive dyskinesia;Baldessarini, R.J.;TINS,1979
4. Sustained gamma aminobutyric acid receptor stimulation and chronic neuroleptic effects;Lloyd, K.G.; Worms, P.;Adv Biochem Psychopharmacol,1980
5. Effect of the muscimol a gaba-mimetic agent, on dopamine metabolism in the mouse brain;Biggio, G.; Casu, M.; Corda, M.G.; Vernaleone, F.; Gessa, G.L.;Life Sci,1977